GILEAD 4331 300 (Viread 300 mg)
Generic Name: tenofovir
Pill imprint GILEAD 4331 300 has been identified as Viread 300 mg.
Viread is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GILEAD 4331 300 (Viread 300 mg)
- Generic Name:
- 300 mg
- 17.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Gilead Sciences
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54569-5334||A S Medication Solutions LLC (repackager)|
|54868-4669||Physicians Total Care Inc (repackager)|
|68258-9003||Dispensing Solutions Inc. (repackager)|
|35356-0073||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...